Hyperfine, Inc. to Participate in Upcoming Investor Conferences
Hyperfine (Nasdaq: HYPR), the company behind the first FDA-cleared portable MR brain imaging system, announced its participation in upcoming investor conferences. Management will present at the H.C. Wainwright 26th Annual Global Investment Conference on September 9, 2024, at 7:00 am ET. They will also host in-person meetings at the 2024 Wells Fargo Healthcare Conference in Boston on September 5th, 2024.
A live webcast of the H.C. Wainwright event and an archived recording will be available on the company's website. The webcast will be accessible for at least 90 days after the event. Hyperfine's groundbreaking Swoop® system has redefined brain imaging with its portability and FDA clearance.
Hyperfine (Nasdaq: HYPR), l'azienda responsabile del primo sistema di imaging cerebrale MR portatile approvato dalla FDA, ha annunciato la sua partecipazione ai prossimi conferenze per investitori. La dirigenza presenterà al 26° Annual Global Investment Conference di H.C. Wainwright il 9 settembre 2024 alle 7:00 ET. Inoltre, organizzeranno incontri di persona al 2024 Wells Fargo Healthcare Conference a Boston il 5 settembre 2024.
Una diretta webcast dell'evento H.C. Wainwright e una registrazione archiviata saranno disponibili sul sito web dell'azienda. La diretta sarà accessibile per almeno 90 giorni dopo l'evento. Il rivoluzionario sistema Swoop® di Hyperfine ha ridefinito l'imaging cerebrale grazie alla sua portabilità e all'approvazione della FDA.
Hyperfine (Nasdaq: HYPR), la compañía detrás del primer sistema portátil de imagen cerebral MR aprobado por la FDA, anunció su participación en las próximas conferencias para inversores. La dirección presentará en la 26ª Conferencia Global de Inversiones Anual de H.C. Wainwright el 9 de septiembre de 2024 a las 7:00 am ET. También llevarán a cabo reuniones presenciales en la Conferencia de Salud de Wells Fargo 2024 en Boston el 5 de septiembre de 2024.
Una transmisión en vivo del evento de H.C. Wainwright y una grabación archivada estarán disponibles en el sitio web de la compañía. La webcast será accesible durante al menos 90 días después del evento. El innovador sistema Swoop® de Hyperfine ha redefinido la imagen cerebral con su portabilidad y aprobación de la FDA.
Hyperfine (Nasdaq: HYPR)는 FDA에서 승인된 첫 번째 휴대용 MR 뇌 이미징 시스템 뒤에 있는 회사로서, 다가오는 투자자 회의에 참여한다고 발표했습니다. 경영진은 H.C. Wainwright 제26회 글로벌 투자 회의에서 2024년 9월 9일 오전 7시 ET에 발표할 예정입니다. 또한 2024년 웰스파고 헬스케어 컨퍼런스에서 2024년 9월 5일에 대면 미팅을 주최할 것입니다.
H.C. Wainwright 이벤트의 생중계와 아카이브 녹음은 회사 웹사이트에서 제공될 것입니다. 생중계는 이벤트 후 최소 90일간 접근 가능합니다. Hyperfine의 혁신적인 Swoop® 시스템은 휴대성과 FDA 승인을 통해 뇌 이미징의 개념을 재정의했습니다.
Hyperfine (Nasdaq: HYPR), la société derrière le premier système d'imagerie cérébrale MR portable approuvé par la FDA, a annoncé sa participation à de prochaines conférences pour investisseurs. La direction présentera à la 26ème Conférence Annuelle Mondiale d'Investissement de H.C. Wainwright le 9 septembre 2024 à 7h00 ET. Ils organiseront également des réunions en personne lors de la Conférence de Santé Wells Fargo 2024 à Boston le 5 septembre 2024.
Un webinaire en direct de l'événement H.C. Wainwright et un enregistrement archivé seront disponibles sur le site Web de l'entreprise. Le webinaire sera accessible pendant au moins 90 jours après l'événement. Le système Swoop® révolutionnaire de Hyperfine a redéfini l'imagerie cérébrale grâce à sa portabilité et à son approbation par la FDA.
Hyperfine (Nasdaq: HYPR), das Unternehmen hinter dem ersten von der FDA genehmigten tragbaren MR-Hirn- bildgebungssystem, kündigte seine Teilnahme an bevorstehenden Investorenkonferenzen an. Das Management wird am 9. September 2024 um 7:00 Uhr ET auf der 26. jährlichen globalen Investmentkonferenz von H.C. Wainwright präsentieren. Außerdem werden persönliche Meetings auf der 2024 Wells Fargo Healthcare Conference in Boston am 5. September 2024 stattfinden.
Ein Live-Webcast des H.C. Wainwright-Events und eine archivierte Aufnahme werden auf der Unternehmenswebsite verfügbar sein. Der Webcast wird mindestens 90 Tage nach der Veranstaltung zugänglich sein. Das bahnbrechende Swoop®-System von Hyperfine hat die Hirnbildgebung durch seine Tragbarkeit und FDA-Zulassung neu definiert.
- None.
- None.
A live webcast of the H.C. Wainwright event, as well as an archived recording, will be available on the “Investors” section of the company’s website at: investors.hyperfine.io. The webcast will be archived and available for replay for at least 90 days after the event.
For more information about the Swoop® Portable MR Imaging® system, please visit hyperfine.io.
About Hyperfine, Inc. and the Swoop® Portable MR Imaging® System
Hyperfine, Inc. (Nasdaq: HYPR) is the groundbreaking health technology company that has redefined brain imaging with the Swoop® system—the first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system capable of providing imaging at multiple points of care. The Swoop® system received initial
The mission of Hyperfine, Inc. is to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging and data solutions. Founded by Dr. Jonathan Rothberg in a technology-based incubator called 4Catalyzer, Hyperfine, Inc. scientists, engineers, and physicists developed the Swoop® system out of a passion for redefining brain imaging methodology and how clinicians can apply accessible diagnostic imaging to patient care. Traditionally, access to costly, stationary, conventional MRI technology can be inconvenient or not available when needed most. With the portable, ultra-low-field Swoop® system, Hyperfine, Inc. is redefining the neuroimaging workflow by bringing brain imaging to the patient’s bedside. For more information, visit hyperfine.io.
Hyperfine, Swoop, and Portable MR Imaging are registered trademarks of Hyperfine, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240828827053/en/
Investor Contact
Webb Campbell
Gilmartin Group LLC
webb@gilmartinir.com
Source: Hyperfine, Inc.
FAQ
When is Hyperfine (HYPR) presenting at the H.C. Wainwright Global Investment Conference?
Where can I watch the webcast of Hyperfine's (HYPR) presentation at the H.C. Wainwright conference?
What is Hyperfine's (HYPR) main product?
When is Hyperfine (HYPR) participating in the Wells Fargo Healthcare Conference?
